Roche Philippines Cuts Tamiflu Price In Fight Against H1N1
This article was originally published in PharmAsia News
Executive Summary
Roche Philippines announced a price cut for its Tamiflu (oseltamivir) flu drug in the Philippines as part of an effort to ensure an adequate supply of the drug worldwide. Other antiviral drugs are expected to be lowered to compete with Roche, which said it was lowering its price to allow the drug to be more affordable for the nation to treat the H1N1 flu virus threat. The drug is not patented in the Philippines, so generics makers are free to market their own versions in the country. (Click here for more